in ,

Former BlueVoyant Exec Amy Williams Named VP of CMMC at Coalfire Federal

Former BlueVoyant Exec Amy Williams Named VP of CMMC at Coalfire Federal - top government contractors - best government contracting event

Amy Williams, formerly senior director of proactive services at BlueVoyant, has joined cybersecurity services provider Coalfire Federal as vice president of Cybersecurity Maturity Model Certification.

Williams, who brings to the role over a decade of industry experience in cybersecurity management and compliance, will be responsible for building a team to provide advisory services to customers preparing for the Department of Defense’s CMMC framework, Coalfire said Monday.

“CMMC advisory services are (or should be) very different from CMMC assessment services but both should be performed by dedicated team members who have adequate experience, credentials and organizational guidance,” commented Williams.

Before joining BlueVoyant, Williams was VP of cybersecurity at Unlimited Technologies and director of cyber at the New York Citizens Crime Commission.

Louisville, Colorado-headquartered Coalfire offers a full suite of CMMC advisory and assessment services to the defense industrial base.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Executive Moves

mm

Written by Naomi Cooper

is a full-time writer for ArchIntel, a division of Executive Mosaic, and a contributor for ExecutiveBiz. She covers emerging technologies, technology innovation, contract awards, partnerships and market expansion stories in the government contracting industry.

DARPA Eyes Microelectronic Sensors Capable of Extreme Temperature Operations - top government contractors - best government contracting event
DARPA Eyes Microelectronic Sensors Capable of Extreme Temperature Operations
Google Releases AI-Based Tools to Support Biotech Drug Discovery, Public Health Initiatives - top government contractors - best government contracting event
Google Releases AI-Based Tools to Support Biotech Drug Discovery, Public Health Initiatives